Cytotheryx, Inc., a Rochester, MN-based biotech company focused on liver cell research, raised $60 million in a Series A fundraising round led by Ouroboros Family Founders Fund I, LP. QRS Investments, LLC also provided parallel debt financing.
More on VCNewsDaily →


